Answers are grounded in this paper and cite their sources.
Since Botulinum toxin A became a mainstay therapy for blepharospasm, its use in treating other dystonic conditions, spasticity disorders, as well as hyperfunctional lines of the face has increased exponentially in recent years. The following article summarizes our experience in establishing a safe and reliable method of administration of botulinum toxin A for treating hyperfunctional lines of the face.
No takes yet. Share an insight, caveat, or question.
Binder et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: